PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $410,700 | -28.4% | 39,758 | -9.1% | 0.00% | 0.0% |
| Q2 2023 | $573,300 | +37.2% | 43,730 | +17.0% | 0.00% | 0.0% |
| Q1 2023 | $417,730 | +30.6% | 37,364 | -1.6% | 0.00% | 0.0% |
| Q4 2022 | $319,961 | -48.7% | 37,955 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $624,000 | +9.1% | 37,454 | -3.6% | 0.00% | 0.0% |
| Q2 2022 | $572,000 | -18.6% | 38,867 | +37.1% | 0.00% | 0.0% |
| Q1 2022 | $703,000 | -29.8% | 28,352 | -9.2% | 0.00% | 0.0% |
| Q4 2021 | $1,002,000 | -8.3% | 31,234 | +2.9% | 0.00% | 0.0% |
| Q3 2021 | $1,093,000 | -29.2% | 30,368 | -13.2% | 0.00% | -50.0% |
| Q2 2021 | $1,544,000 | +92.8% | 34,986 | +99.8% | 0.00% | +100.0% |
| Q1 2021 | $801,000 | -33.9% | 17,508 | -0.3% | 0.00% | -50.0% |
| Q4 2020 | $1,212,000 | – | 17,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |